Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Recurrence, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT01097239 2020-11-20

Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer

Phase 1/2 Withdrawn

GastrointestinalGynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Rectal Neoplasms, Vaginal Neoplasms, Endometrial Neoplasms

NCT02713984 2020-03-19

A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer

Phase 1/2 Withdrawn

BreastCNSGastrointestinalGynecologicThoracic

Breast Neoplasms, Glioma, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Recurrence, Stomach Neoplasms, Colorectal Neoplasms

NCT03281681 2019-10-18

REPROVe

Phase 1/2 Withdrawn

Gynecologic

Ovarian Neoplasms

NCT00562185 2017-11-20

Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer

Phase 1/2 Withdrawn

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00603460 2017-05-02

DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer

Phase 1/2 Withdrawn

Gynecologic

Ovarian Neoplasms

NCT01624493 2015-12-23

BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients

Phase 1/2 Withdrawn

Gynecologic

Ovarian Neoplasms

NCT01880996 2015-06-11

Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies

Phase 1/2 Withdrawn

Gynecologic

Fatigue, Ovarian Neoplasms, Parasomnias

Clinical Trials

ANGELICA

A Master Protocol Study to Investigate Biomarker-guided Novel Anticancer Agent(s) as Monotherapy or Combination Therapy in Participants With Advanced/Recurrent Ovarian Cancer

Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian Cancer

Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC)

CHUV-OVACURE

QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy

Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Safety and Efficacy of IV Nerofe™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer

A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer

REPROVe

Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer

DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer

BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients

Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies